# Peptides in 2 — Episode 14: Survodutide

Weight and liver evidence. Evidence cutoff: October 14, 2026. Published October 14, 2026.

1:56, 1920×1080, 24 fps. The original content narration plus two matching transitions and one continuous replacement closing. Generation speed 0.85; voice tempo remains 1.0. The two former graph pauses now contain explanatory transitions. Opening approximately 104 words/minute. Four new technology artworks and a new quiet instrumental score.

## Measured sequence

| Seconds | Visual |
|---|---|
| 0–88.34 | Existing content, including MRI; both narration gaps filled |
| 88.34–101.00 | Existing development status |
| 101.00–108.45 | One stable closing-summary panel |
| 108.45–109.05 | One soft dissolve into the WPF end card |
| 109.05–116.00 | WPF sign-off and final fade |

## Scientific controls

Use the treatment-regimen estimand consistently for both numerical graphics. Weight means and true 95% confidence intervals are distinct from liver-fat responder proportions. Keep studies, populations, durations and measurements separate. Show the 218 randomized/216 treated distinction for the liver trial and use the corrected primary article. Credit corporate partners separately from investigators. No cross-trial ranking or invented molecular animation.

## Deliverables and checks

Published MP4, source pack, evidence notes, transcript, captions, thumbnail, plan and website copy. Verify full decode, runtime/format, all narration windows and closing, quiet-gap reading pauses, clinical values/intervals, caption timing and artwork originality. Paid video generation: none.

Final closing: one uninterrupted Tom recording covers the takeaway, complete WPF sign-off. Only two long silent breaths are shortened; no spoken audio is sped up or slowed down. One soft dissolve moves from the summary to the WPF card, with no return to another content screen. The soundtrack and picture before 1:41 remain as accepted.

The preview of the following film is removed from the status screen, voice track and captions. The sign-off follows the final takeaway directly.